Fetal and neonatal bilirubin metabolism

Human fetal and neonatal bilirubin metabolism is centered on 4Z,15Z-bilirubin IXα (BR) due to the extremely low BR conjugating capacity of the liver. BR is a unique, highly lipophilic substance with physiological and toxic effects in the cell membranes of organs and body tissues. The fetus excretes...

Full description

Bibliographic Details
Main Authors: Susumu Itoh, Hitoshi Okada, Kosuke Koyano, Shinji Nakamura, Yukihiko Konishi, Takashi Iwase, Takashi Kusaka
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.1002408/full
_version_ 1811170444355567616
author Susumu Itoh
Hitoshi Okada
Kosuke Koyano
Shinji Nakamura
Yukihiko Konishi
Takashi Iwase
Takashi Kusaka
author_facet Susumu Itoh
Hitoshi Okada
Kosuke Koyano
Shinji Nakamura
Yukihiko Konishi
Takashi Iwase
Takashi Kusaka
author_sort Susumu Itoh
collection DOAJ
description Human fetal and neonatal bilirubin metabolism is centered on 4Z,15Z-bilirubin IXα (BR) due to the extremely low BR conjugating capacity of the liver. BR is a unique, highly lipophilic substance with physiological and toxic effects in the cell membranes of organs and body tissues. The fetus excretes BR through the placenta to the maternal circulation. After birth, BR is thought to act as an antioxidant against the increase in reactive oxygen species caused by the rapid increase in oxygen concentration during the adaptation process from in amniotic fluid to in air. However, bilirubin encephalopathy is a toxic effect of bilirubin. Due to the lipophilic nature of BR, it must be bound to a carrier to be distributed to various parts of the body by hydrophilic blood. This carrier of BR is human serum albumin (HSA). In humans, BR can be excreted efficiently after undergoing photochemical reactions upon high affinity binding to HSA. HSA also plays an important role in the prevention of bilirubin encephalopathy. This review focuses on the developmental and physiological role of bilirubin metabolism during the fetal and neonatal periods.
first_indexed 2024-04-10T16:56:53Z
format Article
id doaj.art-e5109605a1104be0b7e930a96ef05f0d
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-10T16:56:53Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-e5109605a1104be0b7e930a96ef05f0d2023-02-07T05:57:08ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-02-011010.3389/fped.2022.10024081002408Fetal and neonatal bilirubin metabolismSusumu Itoh0Hitoshi Okada1Kosuke Koyano2Shinji Nakamura3Yukihiko Konishi4Takashi Iwase5Takashi Kusaka6Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, JapanDivision of Analytical Technology, Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Kagawa, JapanMaternal Perinatal Center, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, JapanHuman fetal and neonatal bilirubin metabolism is centered on 4Z,15Z-bilirubin IXα (BR) due to the extremely low BR conjugating capacity of the liver. BR is a unique, highly lipophilic substance with physiological and toxic effects in the cell membranes of organs and body tissues. The fetus excretes BR through the placenta to the maternal circulation. After birth, BR is thought to act as an antioxidant against the increase in reactive oxygen species caused by the rapid increase in oxygen concentration during the adaptation process from in amniotic fluid to in air. However, bilirubin encephalopathy is a toxic effect of bilirubin. Due to the lipophilic nature of BR, it must be bound to a carrier to be distributed to various parts of the body by hydrophilic blood. This carrier of BR is human serum albumin (HSA). In humans, BR can be excreted efficiently after undergoing photochemical reactions upon high affinity binding to HSA. HSA also plays an important role in the prevention of bilirubin encephalopathy. This review focuses on the developmental and physiological role of bilirubin metabolism during the fetal and neonatal periods.https://www.frontiersin.org/articles/10.3389/fped.2022.1002408/fullbilirubin photoisomersbreast milk jaundicehuman serum albuminneonatal jaundicephysiological effectsreactive oxygen species
spellingShingle Susumu Itoh
Hitoshi Okada
Kosuke Koyano
Shinji Nakamura
Yukihiko Konishi
Takashi Iwase
Takashi Kusaka
Fetal and neonatal bilirubin metabolism
Frontiers in Pediatrics
bilirubin photoisomers
breast milk jaundice
human serum albumin
neonatal jaundice
physiological effects
reactive oxygen species
title Fetal and neonatal bilirubin metabolism
title_full Fetal and neonatal bilirubin metabolism
title_fullStr Fetal and neonatal bilirubin metabolism
title_full_unstemmed Fetal and neonatal bilirubin metabolism
title_short Fetal and neonatal bilirubin metabolism
title_sort fetal and neonatal bilirubin metabolism
topic bilirubin photoisomers
breast milk jaundice
human serum albumin
neonatal jaundice
physiological effects
reactive oxygen species
url https://www.frontiersin.org/articles/10.3389/fped.2022.1002408/full
work_keys_str_mv AT susumuitoh fetalandneonatalbilirubinmetabolism
AT hitoshiokada fetalandneonatalbilirubinmetabolism
AT kosukekoyano fetalandneonatalbilirubinmetabolism
AT shinjinakamura fetalandneonatalbilirubinmetabolism
AT yukihikokonishi fetalandneonatalbilirubinmetabolism
AT takashiiwase fetalandneonatalbilirubinmetabolism
AT takashikusaka fetalandneonatalbilirubinmetabolism